The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromes
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study
1982 • 521 citations
Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis
1985 • 217 citations
Causes of initial remission induction failure in acute myelogenous leukemia
1982 • 201 citations
Response of Preleukemic Syndromes to Continuous Infusion of Low-Dose Cytarabine
1983 • 179 citations
Does treatment with ARA-C in low dosage cause differentiation of leukemic cells?
1983 • 175 citations
Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes.
1983 • 147 citations
Therapy of Secondary Acute Nonlymphocytic Leukemia with Cytarabine
1983 • 133 citations
Treatment of acute myeloid leukaemia with a triple cytotoxic regime: dat
1977 • 123 citations
Effect of chemotherapy for the dysmyelopoietic syndrome.
1981 • 112 citations
Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromes
1984 • 108 citations
Allogeneic Marrow Transplantation in the Treatment of Preleukemia
1984 • 104 citations
Prediction of response of acute nonlymphocytic leukaemia to therapy with ‘high dose’ cytosine arabinoside
1984 • 55 citations
The effect of low dose Ara-C in acute non-lymphoblastic leukaemias and atypical leukaemia
1984 • 52 citations
The myelodysplastic syndromes
2008 • 36 citations
Bone marrow transplantation performed as first-time treatment in two cases of secondary acute myeloid leukemia
1984 • 21 citations
THE DIAGNOSIS OF PRELEUKAEMIA
1983 • 17 citations